December 12, 2022 – Enacting Medicaid expansion in Texas and increasing the use of preventive and antiviral medications could result in a decline of new HIV infections among young Black gay, bisexual, and other men who have sex with men (MSM) in Houston, reports a study in the January issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Expanding Medicaid, as a number of states have already done, may help substantially reduce the burden of HIV among underserved populations in Houston and throughout Texas," according to the social network modeling and computer simulation study by lead author Francis Lee, PhD, of the University of Chicago and colleagues. However, the researchers note that additional strategies – focused on increasing the use of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for HIV – would be needed to meet the ultimate goal of eliminating HIV transmission in the city.
Medicaid expansion could reduce high rates of HIV transmission among young Black gay, bisexual, and other MSM
The analysis focused on HIV transmission among young (18 to 34 years) Black gay, bisexual, and other MSM: a disproportionately affected group who account for 19% of all newly diagnosed people in Houston. Along with other interrelated social determinants of health factors such as race, sexual identity, and medical distrust, lack of medical coverage is a key contributor to the high rate of HIV transmission among young Black gay, bisexual, and other MSM, according to other published research cited in the paper.
Expansion of Medicaid coverage under the Affordable Care Act has led to numerous population health benefits, including increased use of effective ART drugs for treatment of HIV infection and PrEP drugs to prevent HIV transmission among people at risk, according to other published research cited in the paper. Texas is one of 11 states that have not adopted Medicaid expansion. That leaves the state as a whole as well as Houston – the most populous city in the Southern United States – with "massive coverage gaps that disproportionately burden people of color," according to the authors.
Dr. Lee and colleagues used a technique called "agent-based network modeling" to simulate the effects of alternative Medicaid expansion strategies on HIV transmission among young Black gay, bisexual, and other MSM in Houston. Simulations projected the effects of Medicaid expansion alone and with the addition of two further strategies that have shown promise in increasing engagement with ART and PrEP.
Study model project possible decrease of HIV incidence rate to almost 50%
In the study models, all three Medicaid expansion scenarios were projected to lead to considerable declines in HIV transmission among young Black gay, bisexual, and other MSM. With Medicaid expansion alone, the HIV incidence rate (new cases per 100 uninfected) was projected to decrease by 17.5% in the tenth year, while the number of new infections would decrease by 14.9%.
The most ambitious strategy examined for increasing the use of ART and PrEP, according to the modeling, would reduce the HIV incidence rate by 48.7% within 10 years, while reducing the number of new infections by 44.0% over the same period. "While Medicaid expansion alone may not get Houston to the goal of zero incidence, expanding PrEP and ART interventions in combination may help achieve this goal," Dr. Lee and coauthors write.
The researchers note that Houston has made "substantial strides" closer to goals aimed at ending the HIV epidemic, focused on increasing the uptake of PrEP and ART. "Improved ART and PrEP engagement have shown promise in reducing HIV transmission in a number of US populations that bear a disproportionate burden of the epidemic," Dr. Lee and colleagues write.
In another sign of progress, the researchers cite a recent federal mandate requiring nearly all insurance plans to provide coverage for PrEP without cost-sharing. "[H]owever," Dr. Lee and colleagues add, "without concerted efforts to reach the uninsured, this change has the potential to increase rather than to decrease the disparities in HIV incidence that disproportionately affect Black MSM."
Aditya S. Khanna, PhD, of Brown University was an equally contributing author with Lee. Kayo Fujimoto, PhD, of the University of Texas Health Science Center at Houston, was senior author of the study. Other researchers were from Houston Health Department, Argonne National Laboratory, University of California Los Angeles, and University of Chicago.
Read [Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study]
About Medical Care
Rated as one of the top ten journals in health care administration, Medical Care is devoted to all aspects of the administration and delivery of health care. This scholarly journal publishes original, peer-reviewed papers documenting the most current developments in the rapidly changing field of health care. Medical Care provides timely reports on the findings of original investigations into issues related to the research, planning, organization, financing, provision, and evaluation of health services. In addition, numerous special supplementary issues that focus on specialized topics are produced with each volume. Medical Care is the official journal of the Medical Care Section of the American Public Health Association.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.